Iovance Biotherapeutics appointed Marc R Theoret as SVP Regulatory Strategy on July 11, 2025.
1 report, 1 independent
Updated Jul 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Iovance Biotherapeutics appointed Marc R Theoret as SVP Regulatory Strategy on July 11, 2025.
Who's involved
What this event is mainly aboutIovance BiotherapeuticsMarc R Theoret
Keep exploring
The entities involved
-
Iovance Biotherapeutics
American biopharmaceutical startup
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireIovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)